PhytoHealth Corporation (TPE:4108)
13.30
+0.25 (1.92%)
Mar 10, 2026, 1:35 PM CST
PhytoHealth Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 86.8 | 22.72 | 62.76 | 100.46 | 94.01 | Upgrade
|
| Short-Term Investments | 981.43 | 1,045 | 1,192 | 1,244 | 1,311 | Upgrade
|
| Trading Asset Securities | 2.5 | 12 | 11 | 16.52 | 10.01 | Upgrade
|
| Cash & Short-Term Investments | 1,071 | 1,080 | 1,266 | 1,361 | 1,415 | Upgrade
|
| Cash Growth | -0.88% | -14.68% | -6.95% | -3.82% | 86.50% | Upgrade
|
| Accounts Receivable | 36.34 | 40.57 | 35.68 | 25.51 | 20.22 | Upgrade
|
| Other Receivables | 0.03 | 27.55 | 28.88 | 29.42 | 29.73 | Upgrade
|
| Receivables | 36.36 | 68.12 | 64.56 | 54.93 | 49.95 | Upgrade
|
| Inventory | 126.08 | 157.18 | 167.73 | 151.59 | 151.77 | Upgrade
|
| Prepaid Expenses | 30.68 | 0.5 | 0.25 | 0.71 | 0.85 | Upgrade
|
| Other Current Assets | 0.07 | 0.38 | 0.82 | 0.51 | 0.77 | Upgrade
|
| Total Current Assets | 1,264 | 1,306 | 1,499 | 1,568 | 1,618 | Upgrade
|
| Property, Plant & Equipment | 184.45 | 213.08 | 246.29 | 274.38 | 307.42 | Upgrade
|
| Long-Term Investments | 838.56 | 849.89 | 527.02 | 434.37 | 450.02 | Upgrade
|
| Goodwill | - | 31.18 | 31.18 | 31.18 | 31.18 | Upgrade
|
| Other Intangible Assets | 60.01 | 35.31 | 42.76 | 50.54 | 58.62 | Upgrade
|
| Other Long-Term Assets | 6.13 | 3.83 | 3.82 | 5.7 | 4.83 | Upgrade
|
| Total Assets | 2,353 | 2,440 | 2,351 | 2,365 | 2,470 | Upgrade
|
| Accounts Payable | 5.86 | 7.99 | 2.5 | 5.79 | 1.99 | Upgrade
|
| Accrued Expenses | - | 27.78 | 33.36 | - | - | Upgrade
|
| Current Portion of Leases | 7.46 | 6.46 | 10.54 | 9.96 | 10.53 | Upgrade
|
| Current Unearned Revenue | 1.13 | 1.19 | 2.73 | 3.34 | 6.12 | Upgrade
|
| Other Current Liabilities | 31.66 | 10.98 | 8.25 | 43.03 | 37.58 | Upgrade
|
| Total Current Liabilities | 46.12 | 54.4 | 57.38 | 62.12 | 56.22 | Upgrade
|
| Long-Term Leases | 8.27 | 11.88 | 17.46 | 20.05 | 20.34 | Upgrade
|
| Other Long-Term Liabilities | 5.04 | 5.01 | 5.01 | 5.01 | 5 | Upgrade
|
| Total Liabilities | 59.42 | 71.29 | 79.85 | 87.18 | 81.56 | Upgrade
|
| Common Stock | 1,986 | 1,986 | 1,986 | 1,986 | 1,986 | Upgrade
|
| Additional Paid-In Capital | 6.35 | 5.85 | 1.16 | 0.52 | 356.85 | Upgrade
|
| Retained Earnings | -282.06 | -264.61 | -191.11 | -156.83 | -441.02 | Upgrade
|
| Comprehensive Income & Other | 162.31 | 173.93 | 130.86 | 78.05 | 78.67 | Upgrade
|
| Total Common Equity | 1,873 | 1,901 | 1,927 | 1,908 | 1,981 | Upgrade
|
| Minority Interest | 420.87 | 467.02 | 343.56 | 369.52 | 407.86 | Upgrade
|
| Shareholders' Equity | 2,294 | 2,368 | 2,271 | 2,277 | 2,389 | Upgrade
|
| Total Liabilities & Equity | 2,353 | 2,440 | 2,351 | 2,365 | 2,470 | Upgrade
|
| Total Debt | 15.73 | 18.34 | 28 | 30 | 30.87 | Upgrade
|
| Net Cash (Debt) | 1,055 | 1,062 | 1,238 | 1,331 | 1,384 | Upgrade
|
| Net Cash Growth | -0.65% | -14.23% | -6.96% | -3.84% | 86.57% | Upgrade
|
| Net Cash Per Share | 5.26 | 5.35 | 6.23 | 6.70 | 7.07 | Upgrade
|
| Filing Date Shares Outstanding | 206.89 | 198.62 | 198.62 | 198.62 | 198.62 | Upgrade
|
| Total Common Shares Outstanding | 206.89 | 198.62 | 198.62 | 198.62 | 198.62 | Upgrade
|
| Working Capital | 1,218 | 1,252 | 1,442 | 1,506 | 1,562 | Upgrade
|
| Book Value Per Share | 9.05 | 9.57 | 9.70 | 9.61 | 9.97 | Upgrade
|
| Tangible Book Value | 1,813 | 1,835 | 1,853 | 1,826 | 1,891 | Upgrade
|
| Tangible Book Value Per Share | 8.76 | 9.24 | 9.33 | 9.19 | 9.52 | Upgrade
|
| Land | - | 96.69 | 96.69 | 96.69 | 96.69 | Upgrade
|
| Buildings | - | 18.77 | 18.77 | 18.77 | 18.77 | Upgrade
|
| Machinery | - | 125.52 | 135.49 | 159.83 | 158.59 | Upgrade
|
| Leasehold Improvements | - | 324.34 | 328.28 | 328.92 | 328.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.